A detailed history of Analyst Ims Investment Management Services Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Analyst Ims Investment Management Services Ltd. holds 1,527 shares of BIIB stock, worth $344,567. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,527
Previous 1,488 2.62%
Holding current value
$344,567
Previous $385,000 14.55%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $8,268 - $10,440
39 Added 2.62%
1,527 $329,000
Q1 2022

Apr 28, 2022

SELL
$193.77 - $244.14 $16,276 - $20,507
-84 Reduced 5.34%
1,488 $313,000
Q2 2021

Aug 05, 2021

SELL
$259.0 - $414.71 $176,120 - $282,002
-680 Reduced 30.2%
1,572 $544,000
Q1 2020

May 11, 2020

SELL
$268.85 - $341.04 $754,393 - $956,958
-2,806 Reduced 55.48%
2,252 $713,000
Q4 2019

Jan 27, 2020

SELL
$220.06 - $304.07 $308,084 - $425,698
-1,400 Reduced 21.68%
5,058 $1.5 Million
Q2 2019

Aug 05, 2019

SELL
$219.29 - $241.72 $91,005 - $100,313
-415 Reduced 6.04%
6,458 $1.51 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $1.86 Million - $2.91 Million
-8,573 Reduced 55.5%
6,873 $1.62 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $2.14 Million - $2.71 Million
7,683 Added 98.97%
15,446 $4.61 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $137,656 - $180,016
-469 Reduced 5.7%
7,763 $2.75 Million
Q2 2018

Jul 25, 2018

SELL
$257.52 - $306.91 $21,116 - $25,166
-82 Reduced 0.99%
8,232 $2.38 Million
Q1 2018

May 10, 2018

SELL
$260.13 - $367.91 $35,117 - $49,667
-135 Reduced 1.6%
8,314 $2.28 Million
Q4 2017

Feb 08, 2018

SELL
$307.64 - $344.58 $69,526 - $77,875
-226 Reduced 2.61%
8,449 $2.69 Million
Q3 2017

Nov 13, 2017

SELL
$281.15 - $329.69 $8,434 - $9,890
-30 Reduced 0.34%
8,675 $2.69 Million
Q2 2017

Aug 07, 2017

BUY
N/A
8,705
8,705 $2.36 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Analyst Ims Investment Management Services Ltd. Portfolio

Follow Analyst Ims Investment Management Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Analyst Ims Investment Management Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Analyst Ims Investment Management Services Ltd. with notifications on news.